Found: 77
Select item for more details and to access through your institution.
Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1540, doi. 10.1007/s10637-019-00890-5
- By:
- Publication type:
- Article
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 791, doi. 10.1007/s10637-017-0486-4
- By:
- Publication type:
- Article
Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 3, p. 394, doi. 10.1007/s10637-016-0329-8
- By:
- Publication type:
- Article
Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 3, p. 347, doi. 10.1007/s10637-016-0347-6
- By:
- Publication type:
- Article
Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 380, doi. 10.1007/s10637-014-0196-0
- By:
- Publication type:
- Article
Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: Phase I study in Japanese patients with advanced solid malignancies and advanced breast cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 5, p. 946, doi. 10.1007/s10637-014-0112-7
- By:
- Publication type:
- Article
A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 599, doi. 10.1007/s10637-012-9833-7
- By:
- Publication type:
- Article
Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 639, doi. 10.1007/s10637-010-9565-5
- By:
- Publication type:
- Article
Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR -Activating Mutation.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 14, p. N.PAG, doi. 10.3390/cells11142201
- By:
- Publication type:
- Article
Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.
- Published in:
- International Journal of Cancer, 2004, v. 108, n. 1, p. 146, doi. 10.1002/ijc.11528
- By:
- Publication type:
- Article
Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines.
- Published in:
- International Journal of Cancer, 2003, v. 104, n. 2, p. 238, doi. 10.1002/ijc.10921
- By:
- Publication type:
- Article
Induction of preneoplastic lung lesions in guinea pigs by cigarette smoke inhalation and their exacerbation by high dietary levels of vitamins C and E.
- Published in:
- Carcinogenesis, 2005, v. 26, n. 3, p. 605, doi. 10.1093/carcin/bgh341
- By:
- Publication type:
- Article
Blockade of EGFR Activation Promotes TNF-Induced Lung Epithelial Cell Apoptosis and Pulmonary Injury.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 16, p. 4021, doi. 10.3390/ijms20164021
- By:
- Publication type:
- Article
P-Glycoprotein Is Positively Correlated with p53 Protein Accumulation in Human Colorectal Cancers.
- Published in:
- Cancer Science, 1997, v. 88, n. 8, p. 738, doi. 10.1111/j.1349-7006.1997.tb00445.x
- By:
- Publication type:
- Article
Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 5, p. 307, doi. 10.1159/000475879
- By:
- Publication type:
- Article
Re: Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2004
- By:
- Publication type:
- Letter
High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
- Published in:
- International Journal of Oncology, 2021, v. 58, n. 1, p. 57
- By:
- Publication type:
- Article
Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.
- Published in:
- Oncogene, 2003, v. 22, n. 18, p. 2812, doi. 10.1038/sj.onc.1206388
- By:
- Publication type:
- Article
Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer.
- Published in:
- Genes, 2022, v. 13, n. 12, p. 2183, doi. 10.3390/genes13122183
- By:
- Publication type:
- Article
Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2024, v. 484, n. 6, p. 1005, doi. 10.1007/s00428-023-03671-x
- By:
- Publication type:
- Article
Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.
- Published in:
- Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13941
- By:
- Publication type:
- Article
Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 5, p. 858, doi. 10.1007/s12282-024-01600-7
- By:
- Publication type:
- Article
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 3, p. 335, doi. 10.1007/s12282-024-01550-0
- By:
- Publication type:
- Article
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 4, p. 657, doi. 10.1007/s12282-023-01461-6
- By:
- Publication type:
- Article
Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.
- Published in:
- Breast Cancer (13406868), 2022, v. 29, n. 1, p. 131, doi. 10.1007/s12282-021-01290-5
- By:
- Publication type:
- Article
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 4, p. 945, doi. 10.1007/s12282-021-01232-1
- By:
- Publication type:
- Article
Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 3, p. 710, doi. 10.1007/s12282-020-01207-8
- By:
- Publication type:
- Article
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
- Published in:
- Breast Cancer (13406868), 2020, v. 27, n. 3, p. 322, doi. 10.1007/s12282-020-01085-0
- By:
- Publication type:
- Article
Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 2, p. 235, doi. 10.1007/s12282-018-0919-8
- By:
- Publication type:
- Article
HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 5, p. 605, doi. 10.1007/s12282-018-0861-9
- By:
- Publication type:
- Article
The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer, 2015 edition.
- Published in:
- Breast Cancer (13406868), 2016, v. 23, n. 3, p. 329, doi. 10.1007/s12282-016-0670-y
- By:
- Publication type:
- Article
The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer.
- Published in:
- Breast Cancer (13406868), 2015, v. 22, n. 1, p. 5, doi. 10.1007/s12282-014-0563-x
- By:
- Publication type:
- Article
Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B.
- Published in:
- Breast Cancer (13406868), 2013, v. 20, n. 2, p. 131, doi. 10.1007/s12282-011-0316-z
- By:
- Publication type:
- Article
Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD).
- Published in:
- 2020
- By:
- Publication type:
- journal article
High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin.
- Published in:
- International Journal of Clinical Oncology, 2011, v. 16, n. 3, p. 244, doi. 10.1007/s10147-010-0170-6
- By:
- Publication type:
- Article
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 278, doi. 10.1093/oncolo/oyac233
- By:
- Publication type:
- Article
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
- By:
- Publication type:
- Article
Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer.
- Published in:
- Biomedical Reports, 2017, v. 7, n. 4, p. 380, doi. 10.3892/br.2017.963
- By:
- Publication type:
- Article
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 3, p. 1258, doi. 10.1002/cam4.1995
- By:
- Publication type:
- Article
A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47673-9
- By:
- Publication type:
- Article
Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101902
- By:
- Publication type:
- Article
Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023849
- By:
- Publication type:
- Article
A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE‐BC.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 8, p. 1692, doi. 10.1002/cncr.34088
- By:
- Publication type:
- Article
U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation.
- Published in:
- Journal of Clinical Investigation, 2020, v. 130, n. 1, p. 374, doi. 10.1172/JCI126598
- By:
- Publication type:
- Article